Assessment of the safety and efficacy of combination chemotherapy and PD-1/PD-L1 inhibitor treatment of breast cancer: A meta-analysis

Abstract. Background:. As the efficacy of programmed cell death-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors combined with chemotherapy in curing breast cancer is still controversial, this meta-analysis compares the efficacy and safety of PD-1/PD-L1 inhibitors combined with chemotherapy and...

Full description

Bibliographic Details
Main Authors: Da Qian, Yuhao Xu, Yihao Wu, Jie Qiu, Weimin Hong, Xuli Meng, Yanjie Yin
Format: Article
Language:English
Published: Wolters Kluwer 2023-07-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002631